Surestep Class Action Settles For $45 Million
December 3, 2001
A California based health care company that produces blood glucose monitoring systems for diabetics has settled a class-action lawsuit for $45 million. Lifescan, a subsidiary of Johnson & Johnson, was facing a nationwide class-action suit filed on behalf of hundreds of thousands of diabetics alleging the company marketed its Surestep blood glucose meter for years knowing the product was defective. Attorneys for the plaintiffs claimed the device misidentified blood glucose levels, leading to illnesses and in some cases death. The settlement involves Surestep meters purchased before August 1997.
In December 2000 a Federal criminal judge fined Lifescan $60 million after the company pleaded guilty to charges it knew about the problems with the Surestep meter, yet failed to inform the Food and Drug Administration.
-- Article Courtesy of InjuryBoard.com
More ...
.